166 related articles for article (PubMed ID: 36338727)
1. Knockdown of USP8 inhibits prostate cancer cell growth, proliferation, and metastasis and promotes docetaxel's activity by suppressing the NF-kB signaling pathway.
Islam MT; Chen FZ; Chen HC; Wahid A
Front Oncol; 2022; 12():923270. PubMed ID: 36338727
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion.
Jing X; Chen Y; Chen Y; Shi G; Lv S; Cheng N; Feng C; Xin Z; Zhang L; Wu J
Cancer Manag Res; 2020; 12():2185-2194. PubMed ID: 32273758
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 8 inhibits lipopolysaccharide-triggered pyroptosis of human bronchial epithelial cells by regulating PI3K/AKT and NF-κB pathways.
Liu L; Huan L; Zhang Y; Wei W; Chen Z; Xu D; Huang X; Tan Y; Li H
Allergol Immunopathol (Madr); 2022; 50(2):96-103. PubMed ID: 35257552
[TBL] [Abstract][Full Text] [Related]
4. CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
Chen B; Zhang Y; Li C; Xu P; Gao Y; Xu Y
Arch Med Sci; 2021; 17(1):152-165. PubMed ID: 33488868
[TBL] [Abstract][Full Text] [Related]
5. Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels.
Tang Y; Parmakhtiar B; Simoneau AR; Xie J; Fruehauf J; Lilly M; Zi X
Neoplasia; 2011 Feb; 13(2):108-19. PubMed ID: 21403837
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ubiquitin specific peptidase 8 is effective against 5-fluorouracil resistance in colon cancer via suppressing EGFR and EGFR-mediated signaling pathways.
Xi C; Gong Z; Ye H; Cao L; Yu J
Histol Histopathol; 2024 Feb; 39(2):251-261. PubMed ID: 37222451
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
[TBL] [Abstract][Full Text] [Related]
8. USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway.
Sun J; Shen D; Zheng Y; Ren H; Liu H; Chen X; Gao Y
Onco Targets Ther; 2020; 13():9941-9952. PubMed ID: 33116578
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
10. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
11. USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels.
Duan B; Wang C; Liu Z; Yang X
Cancer Manag Res; 2021; 13():4181-4189. PubMed ID: 34079371
[TBL] [Abstract][Full Text] [Related]
12. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
[TBL] [Abstract][Full Text] [Related]
13. INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
Chen H; Li H; Chen Q
Biochem Biophys Res Commun; 2016 Aug; 477(3):467-72. PubMed ID: 27318090
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.
Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E
J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360
[No Abstract] [Full Text] [Related]
15. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of USP8 Inhibits the Growth of Lung Cancer Cells.
Rong Z; Zhu Z; Cai S; Zhang B
Cancer Manag Res; 2020; 12():12415-12422. PubMed ID: 33293867
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP
J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
19. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
20. USP8 is a novel target for overcoming gefitinib resistance in lung cancer.
Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
